A Phase I/II Clinical Trial of ICP-723 in the Treatment of Advanced Solid Tumors

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE1, PHASE2

מצבים רפואיים

Solid Tumors

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China

    Contact: Study coordinator (Mingjun Zhang, MD)
  • Peking University Cancer Hospital, Beijing, Beijing Municipality, China

    Contact: Study coordinator (Jian Fang, MD)
  • The First Medical Center of the Chinese People's Liberation Army General Hospital, Beijing, Beijing Municipality, China

    Contact: Study coordinator (Yi Hu, MD)
  • Cancer Hospital Affiliated to Guangzhou Medical University, Guangzhou, Guangdong, China

    Contact: Study coordinator (Weidong Li, MD)
  • Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China

    Contact: Study coordinator (Herui Yao, MD)
  • The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, Guangdong, China

    Contact: Study coordinator (Zhong Lin)
    Contact: Study coordinator (Xiaofeng Pei)
  • Sun Yat-Sen University Cancer Center, Guangdong, Guangzhou, China

    Contact: Study coordinator (RuiHua XU, MD) · xurh@sysucc.org.cn · 020-87343533
  • Shijiazhuang People's Hospital, Shijiazhuang, Hebei, China

    Contact: Study coordinator (Jingran Wang, MD)
  • Cancer Hospital Affiliated to Harbin Medical University, Harbin, Heilongjiang, China

    Contact: Study coordinator (Baogang Liu, MD) · 13804552752
  • The First Affiliated Hospital of Henan University of Science and Technology, Luoyang, Henan, China

    Contact: Study coordinator (Shuangshuang Guo)
  • Henan Cancer Hospital, Zhengzhou, Henan, China

    Contact: Study coordinator (Quming Wang, MD)
  • Henan Provincial People's Hospital, Zhengzhou, Henan, China

    Contact: Study coordinator (Shundong Cang, MD) · 13592675836
  • The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China

    Contact: Study coordinator (Xingya Li, MD) · 15618417071
  • Union Hospital, Tongji Medical College,Huazhong University of Science and Technology, Wuhan, Hubei, China

    Contact: Study coordinator (Xiaorong Dong, MD) · 13986252286
  • Hunan Cancer hospital, Changsha, Hunan, China

    Contact: Study coordinator (Lin Wu, MD) · 13170419973
  • Jiangsu Provincial People's Hospital, Nanjing, Jiangsu, China

    Contact: Study coordinator (Yongqian Shu, MD)
  • Affiliated Hospital of Jiangnan University, Wuxi, Jiangsu, China

    Contact: Study coordinator (Yong Mao, MD) · 18651581690
  • The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China

    Contact: Study coordinator (Junhe Li, MD) · 13699505152
  • Affiliated Cancer Hospital of Shandong First Medical University, Jinan, Shandong, China

    Contact: Study coordinator (Zhehai Wang, MD)
  • Affiliated Hospital of Qingdao University, Qingdao, Shandong, China

    Contact: Study coordinator (Jing Wang, MD)
  • Shanxi Cancer Hospital, Taiyuan, Shanxi, China

    Contact: Study coordinator (Hongxia Lu, MD)
  • Yunnan Cancer Hospital, Kunming, Yunnan, China

    Contact: Study coordinator (Runxiang Yang, MD)
  • Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China

    Contact: Study coordinator (Tao Li, MD)
  • The first affiliated hospital Zhejiang university school of medicine, Hangzhou, Zhejiang, China

    Contact: Study coordinator (Nong Xu, MD) · 0571-87236114